# US 2003/0229210 A1 · Process for the preparation of active somatotropin from inclusion bodies

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0229210 A1
- Document ID: US20030229210A1
- Status: Published application
- Kind: A1
- Application number: 09/811,789
- Filed: 2001-01-12
- Published: 2003-12-11
- Earliest claimed: 1998-08-27
- Assignees: LG Chemical Ltd.
- Inventors: Yong-Jun Lee; Hong-Kyun Lee; Kyuboem Han
- Web page: https://patentgrep.com/patent/US20030229210A1

## CPC

- C07K 1/1133: {by redox-reactions involving cystein/cystin side chains}
- C07K 14/61: Growth hormone [GH], i.e. somatotropin
- Y10S 530/824: Yeasts
- Y10S 530/825: Bacteria
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

A process for the preparation of biologically active somatotropin from inclusion bodies of a recombinant host cell containing an inactive form of said somatotropin protein comprises the steps of: (a) contacting the inclusion bodies with an aqueous alcohol solution at an alkaline pH to solubilize said protein; and (b) bringing the solubilized protein into contact with a mild oxidizing agent to refold and form intramolecular disulfide bonds between cysteine residues of said protein.

## Claims

### Claim 1

A process for the preparation of biologically active somatotropin from inclusion bodies of a recombinant host cell containing an inactive form of said somatotropin protein, which comprises the steps of:
(a) contacting the inclusion bodies with an aqueous alcohol solution at an alkaline pH to solubilize said protein; and
(b) bringing the solubilized-protein into contact with a mild oxidizing agent to refold and form intramolecular disulfide bonds between cysteine residues of said protein.

### Claim 2 (depends on 1)

The process of claim 1, wherein the alcohol is n-propyl alcohol or isopropyl alcohol.

### Claim 3 (depends on 2)

The process of claim 2, wherein the concentration of isopropyl alcohol or n-propyl alcohol in step (a) ranges from 10 to 50%.

### Claim 4 (depends on 2)

The process of claim 2, wherein the concentration of isopropyl alcohol or n-propyl alcohol in step (b) ranges from 10 to 35%.

### Claim 5 (depends on 2)

The process of claim 2, wherein isopropyl alcohol or n-propyl alcohol is removed before step (b).

### Claim 6 (depends on 1)

The process of claim 1, wherein the mild oxidizing agent is air.

### Claim 7 (depends on 1)

The process of claim 1, wherein said recombinant host is E. coli.

### Claim 8 (depends on 1)

The process of claim 1, wherein said somatotropin is mammalian, avian or fish somatotropin.

### Claim 9 (depends on 1)

The process of claim 1, wherein said somatotropin is human, bovine, porcine, horse, goat, ovine, canine, feline, chicken, flatfish, rockfish, salmon or eel somatotropin.

### Claim 10 (depends on 1)

The process of claim 1, wherein said process is conducted at a temperature ranging from 0 to 50° C.

### Claim 11 (depends on 1)

The process of claim 1, wherein step (a) is conducted at a pH above 9.

### Claim 12 (depends on 1)

The process of claim 1, wherein step (b) is conducted at a pH above 8.4.

### Claim 13 (depends on 1)

The process of claim 1, wherein the concentration of somatotropin in step (a) ranges from 1 to 10 g/l.

### Claim 14 (depends on 1)

The process of claim 1, wherein a reducing agent is added to the aqueous solution in step (a).

### Claim 15 (depends on 14)

The process of claim 14, wherein said reducing agent is 2-mercaptoethanol, cysteamine, glutathione, cysteine or a redox mixture thereof.

### Claim 16 (depends on 14)

The process of claim 14, wherein said reducing agent is 2-mercaptoethanol used at a concentration ranging from 0.0001% to 0.5%.

### Claim 17 (depends on 1)

The process of claim 1, wherein a reducing agent is added in step (b).

### Claim 18 (depends on 17)

The process of claim 17, wherein said reducing agent is 2-mercaptoethanol, cysteamine, glutathione, cysteine or a mixture thereof.

### Claim 19 (depends on 17)

The process of claim 17, wherein said reducing agent is 2-mercaptoethanol used at a concentration ranging from 0% to 0.25%.
